Rho-associated kinase 2 polymorphism in patients with vasospastic angina

Korean Circulation Journal

Volumn 42, Issue 6, 2012, Pages 406-413

  Yoo, Sang Yong ^a   Kim, Jeonguk ^a   Cheong, Sangsig ^a   Shin, Dae Hee ^a   Jang, Jinkun ^a   Lee, Changkun ^a   Tahk, Seung Jea ^b   Shin, Joon Han ^b   Choi, So Yeon ^b   Yoon, Myeong Ho ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Coronary vasospasm; Haplotypes; Polymorphism, genetic; Rho associated kinase 2

Indexed keywords

ERGOMETRINE; MESSENGER RNA; MYOSIN LIGHT CHAIN; RHO KINASE; RHO KINASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY SPASM; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN PHOSPHORYLATION; PROVOCATION TEST; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; VASOSPASTIC ANGINA;

EID: 84864020805     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2012.42.6.406     Document Type: Article

References (26)

1. Sueda S, Kohno H, Fukuda H, Uraoka T. Did the widespread use of long-acting calcium antagonists decrease the occurrence of variant angina? Chest 2003;124:2074-8. (Pubitemid 38010571)
2. Yoo SY, Shin DH, Jeong JI, et al. Long-term prognosis and clinical characteristics of patients with variant angina. Korean Cir J 2008;38:651-8.
3. Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm: clinical features, diagnosis, pathogenesis, and treatment. J Cardiol 2008;51:2-17. (Pubitemid 351709406)
4. Chahine RA, Raizner AE, Ishimori T, Luchi RJ, McIntosh HD. The incidence and clinical implications of coronary artery spasm. Circulation 1975:52:972-8.
5. Liew M, Pryor R, Palais R, et al. Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin Chem 2004;50:1156-64. (Pubitemid 38824225)
6. Reed GH, Wittwer CT. Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clin Chem 2004;50:1748-54. (Pubitemid 39298003)
7. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 2003;49(6 Pt 1):853-60. (Pubitemid 36623462)
8. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365-86.
9. Shi YY, He L SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97-8. (Pubitemid 41653949)
10. Li Z, Zhang Z, He Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009;19:519-23.
11. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9. (Pubitemid 34680308)
12. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001;22:32-9. (Pubitemid 32126284)
13. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 2001;81:153-208. (Pubitemid 32098004)
14. Noma K, Oyama N, Liao JK. Physiological role of ROCKs in the cardiovascular system. Am J Physiol Cell Physiol 2006;290:C661-8.
15. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003;4:446-56. (Pubitemid 36648590)
16. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 1996;392:189-93. (Pubitemid 26276745)
17. Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol 2002;39:319-27. (Pubitemid 34175055)
18. Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J 2000;64:1-12. (Pubitemid 30073654)
19. Kandabashi T, Shimokawa H, Miyata K, et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation 2000;101:1319-23. (Pubitemid 30158621)
20. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002;105:1545-7. (Pubitemid 34297629)
21. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994;372:231-6. (Pubitemid 24352442)
22. Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 1998;273:24266-71. (Pubitemid 28435775)
23. Wolfrum S, Dendorfer A Rikitake Y, et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 2004;24:1842-7. (Pubitemid 39350301)
24. Kamiunten H, Koike J, Mashiba J, Shimokawa H, Takeshita A A comprehensive analysis of a novel missense mutation in Rho-kinase that causes coronary vasospasm in the Japanese. Circ J 2004;68(suppl I):211. Abstract.
25. Yoo SY, Kim JY. Recent insights into the mechanisms of vasospastic angina. Korean Circ J 2009;39:505-11.
26. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-9. (Pubitemid 23019336)